Tylenol Label Warning Complaint Dismissed With Judge's Federal Preemption Question Unanswered

Marketers of other drugs available under FDA OTC monograph should note dismissal of complaint against Kenvue didn’t resolve the judge’s questions about whether federal preemption precludes challenges to safety and labeling.